A new study suggests COPD patients experience improved lung function ... and failed to show superiority to the older drugs in head-to-head trials. Novartis, by contrast, can claim superiority ...

It plans to estimate the "comparative therapeutic impact" of the two drugs compared to their respective ... in patients with moderate to severe COPD. So far, attempts by the industry to strike ...

The same biological processes that drive aging — such as energy loss — may also contribute to lung diseases like chronic ...

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

The dearth of medical expertise, treatment facilities and requisite diagnostic equipment to accurately diagnose lung cancer at the early stages, and effectively manage is fueling death among people ...

Another patient, Donna, has also benefited from the new cap on Medicare Part D prescription drugs. Living with multiple chronic conditions, she has long faced high prescription drug costs—typically ...

Discover the latest drugs and treatment options in the Psoriasis Pipeline. Dive into DelveInsight's comprehensive report ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...